Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus

PHASE3CompletedINTERVENTIONAL

Enrollment

176

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Diabetic Foot Ulcer Patients With Uncontrolled Diabetes Mellitus

Interventions

DRUG

rhEGF(recombinant human Epidermal Growth Factor)

DRUG

placebo of rhEGF(recombinant human Epidermal Growth Factor)

Trial Locations (1)

College of Medicine, Yonsei University, Seoul